Home » Topics » Regulatory

Regulatory
RSS

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

IVAX's generic estazolam cleared for marketing by FDA

July 8, 1997

Royce Laboratories' generic meperidine approved by FDA

July 8, 1997

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...